腹腔镜与开放式肝切除术治疗左肝细胞癌的手术结果:使用回顾性日本和韩国个体患者数据的倾向评分分析。

IF 11.6 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Liver Cancer Pub Date : 2023-02-01 DOI:10.1159/000527294
Masaki Kaibori, Kengo Yoshii, Yuzo Umeda, Takahito Yagi, Takehiro Okabayashi, Kenta Sui, Akira Mori, Yuhei Hamaguchi, Kiyoshi Kajiyama, Daisuke Hokuto, Kazuteru Monden, Tomoharu Yoshizumi, Yoriko Nomura, Kan Toriguchi, Jong Man Kim, Gi Hong Choi, Je Ho Ryu, Yangseok Koh, Koo Jeong Kang, Young Kyoung You, Kwang-Sik Chun, Young Seok Han, Chan Woo Cho, Young Il Choi, Dong-Sik Kim, Jae Do Yang, Keita Mori, Atsushi Hiraoka, Hiroki Yamaue, Masafumi Nakamura, Masakazu Yamamoto, Itaru Endo
{"title":"腹腔镜与开放式肝切除术治疗左肝细胞癌的手术结果:使用回顾性日本和韩国个体患者数据的倾向评分分析。","authors":"Masaki Kaibori,&nbsp;Kengo Yoshii,&nbsp;Yuzo Umeda,&nbsp;Takahito Yagi,&nbsp;Takehiro Okabayashi,&nbsp;Kenta Sui,&nbsp;Akira Mori,&nbsp;Yuhei Hamaguchi,&nbsp;Kiyoshi Kajiyama,&nbsp;Daisuke Hokuto,&nbsp;Kazuteru Monden,&nbsp;Tomoharu Yoshizumi,&nbsp;Yoriko Nomura,&nbsp;Kan Toriguchi,&nbsp;Jong Man Kim,&nbsp;Gi Hong Choi,&nbsp;Je Ho Ryu,&nbsp;Yangseok Koh,&nbsp;Koo Jeong Kang,&nbsp;Young Kyoung You,&nbsp;Kwang-Sik Chun,&nbsp;Young Seok Han,&nbsp;Chan Woo Cho,&nbsp;Young Il Choi,&nbsp;Dong-Sik Kim,&nbsp;Jae Do Yang,&nbsp;Keita Mori,&nbsp;Atsushi Hiraoka,&nbsp;Hiroki Yamaue,&nbsp;Masafumi Nakamura,&nbsp;Masakazu Yamamoto,&nbsp;Itaru Endo","doi":"10.1159/000527294","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>This study aimed to compare the prognostic impact of laparoscopic left hepatectomy (LLH) with that of open left hepatectomy (OLH) on patient survival after resection of left hepatocellular carcinoma (HCC).</p><p><strong>Methods: </strong>Among the 953 patients who received initial treatment for primary HCC that was resectable by either LLH or OLH from 2013 to 2017 in Japan and Korea, 146 patients underwent LLH and 807 underwent OLH. The inverse probability of treatment weighting approach based on propensity scoring was used to address the potential selection bias inherent in the recurrence and survival outcomes between the LLH and OLH groups.</p><p><strong>Results: </strong>The occurrence rate of postoperative complications and hepatic decompensation was significantly lower in the LLH group than in the OLH group. Recurrence-free survival (RFS) was better in the LLH group than in the OLH group (hazard ratio, 1.33; 95% confidence interval, 1.03-1.71; <i>p</i> = 0.029), whereas overall survival (OS) was not significantly different. Subgroup analyses of RFS and OS revealed an almost consistent trend in favor of LLH over OLH. In patients with tumor sizes of ≥4.0 cm or those with single tumors, both RFS and OS were significantly better in the LLH group than in the OLH group.</p><p><strong>Conclusions: </strong>LLH decreases the risk of tumor recurrence and improves OS in patients with primary HCC located in the left liver.</p>","PeriodicalId":18156,"journal":{"name":"Liver Cancer","volume":"12 1","pages":"32-43"},"PeriodicalIF":11.6000,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/af/e1/lic-0012-0032.PMC9982339.pdf","citationCount":"1","resultStr":"{\"title\":\"Surgical Outcomes of Laparoscopic versus Open Hepatectomy for Left Hepatocellular Carcinoma: Propensity Score Analyses Using Retrospective Japanese and Korean Individual Patient Data.\",\"authors\":\"Masaki Kaibori,&nbsp;Kengo Yoshii,&nbsp;Yuzo Umeda,&nbsp;Takahito Yagi,&nbsp;Takehiro Okabayashi,&nbsp;Kenta Sui,&nbsp;Akira Mori,&nbsp;Yuhei Hamaguchi,&nbsp;Kiyoshi Kajiyama,&nbsp;Daisuke Hokuto,&nbsp;Kazuteru Monden,&nbsp;Tomoharu Yoshizumi,&nbsp;Yoriko Nomura,&nbsp;Kan Toriguchi,&nbsp;Jong Man Kim,&nbsp;Gi Hong Choi,&nbsp;Je Ho Ryu,&nbsp;Yangseok Koh,&nbsp;Koo Jeong Kang,&nbsp;Young Kyoung You,&nbsp;Kwang-Sik Chun,&nbsp;Young Seok Han,&nbsp;Chan Woo Cho,&nbsp;Young Il Choi,&nbsp;Dong-Sik Kim,&nbsp;Jae Do Yang,&nbsp;Keita Mori,&nbsp;Atsushi Hiraoka,&nbsp;Hiroki Yamaue,&nbsp;Masafumi Nakamura,&nbsp;Masakazu Yamamoto,&nbsp;Itaru Endo\",\"doi\":\"10.1159/000527294\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>This study aimed to compare the prognostic impact of laparoscopic left hepatectomy (LLH) with that of open left hepatectomy (OLH) on patient survival after resection of left hepatocellular carcinoma (HCC).</p><p><strong>Methods: </strong>Among the 953 patients who received initial treatment for primary HCC that was resectable by either LLH or OLH from 2013 to 2017 in Japan and Korea, 146 patients underwent LLH and 807 underwent OLH. The inverse probability of treatment weighting approach based on propensity scoring was used to address the potential selection bias inherent in the recurrence and survival outcomes between the LLH and OLH groups.</p><p><strong>Results: </strong>The occurrence rate of postoperative complications and hepatic decompensation was significantly lower in the LLH group than in the OLH group. Recurrence-free survival (RFS) was better in the LLH group than in the OLH group (hazard ratio, 1.33; 95% confidence interval, 1.03-1.71; <i>p</i> = 0.029), whereas overall survival (OS) was not significantly different. Subgroup analyses of RFS and OS revealed an almost consistent trend in favor of LLH over OLH. In patients with tumor sizes of ≥4.0 cm or those with single tumors, both RFS and OS were significantly better in the LLH group than in the OLH group.</p><p><strong>Conclusions: </strong>LLH decreases the risk of tumor recurrence and improves OS in patients with primary HCC located in the left liver.</p>\",\"PeriodicalId\":18156,\"journal\":{\"name\":\"Liver Cancer\",\"volume\":\"12 1\",\"pages\":\"32-43\"},\"PeriodicalIF\":11.6000,\"publicationDate\":\"2023-02-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/af/e1/lic-0012-0032.PMC9982339.pdf\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Liver Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000527294\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"GASTROENTEROLOGY & HEPATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Liver Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000527294","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 1

摘要

前言:本研究旨在比较腹腔镜左肝切除术(LLH)与开放式左肝切除术(OLH)对左肝细胞癌(HCC)切除术后患者生存率的影响。方法:2013年至2017年,日本和韩国953例接受LLH或OLH可切除的原发性HCC初始治疗患者中,146例患者接受LLH, 807例患者接受OLH。基于倾向评分的治疗加权逆概率方法用于解决LLH组和OLH组之间复发和生存结果中固有的潜在选择偏倚。结果:LLH组术后并发症及肝功能失代偿发生率明显低于OLH组。LLH组无复发生存期(RFS)优于OLH组(风险比,1.33;95%置信区间为1.03-1.71;p = 0.029),而总生存期(OS)无显著差异。RFS和OS的亚组分析显示LLH优于OLH的趋势几乎一致。在肿瘤大小≥4.0 cm或单一肿瘤患者中,LLH组的RFS和OS均显著优于OLH组。结论:左肝原发性HCC患者行LLH可降低肿瘤复发风险,改善OS。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

摘要图片

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Surgical Outcomes of Laparoscopic versus Open Hepatectomy for Left Hepatocellular Carcinoma: Propensity Score Analyses Using Retrospective Japanese and Korean Individual Patient Data.

Introduction: This study aimed to compare the prognostic impact of laparoscopic left hepatectomy (LLH) with that of open left hepatectomy (OLH) on patient survival after resection of left hepatocellular carcinoma (HCC).

Methods: Among the 953 patients who received initial treatment for primary HCC that was resectable by either LLH or OLH from 2013 to 2017 in Japan and Korea, 146 patients underwent LLH and 807 underwent OLH. The inverse probability of treatment weighting approach based on propensity scoring was used to address the potential selection bias inherent in the recurrence and survival outcomes between the LLH and OLH groups.

Results: The occurrence rate of postoperative complications and hepatic decompensation was significantly lower in the LLH group than in the OLH group. Recurrence-free survival (RFS) was better in the LLH group than in the OLH group (hazard ratio, 1.33; 95% confidence interval, 1.03-1.71; p = 0.029), whereas overall survival (OS) was not significantly different. Subgroup analyses of RFS and OS revealed an almost consistent trend in favor of LLH over OLH. In patients with tumor sizes of ≥4.0 cm or those with single tumors, both RFS and OS were significantly better in the LLH group than in the OLH group.

Conclusions: LLH decreases the risk of tumor recurrence and improves OS in patients with primary HCC located in the left liver.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Liver Cancer
Liver Cancer Medicine-Oncology
CiteScore
20.80
自引率
7.20%
发文量
53
审稿时长
16 weeks
期刊介绍: Liver Cancer is a journal that serves the international community of researchers and clinicians by providing a platform for research results related to the causes, mechanisms, and therapy of liver cancer. It focuses on molecular carcinogenesis, prevention, surveillance, diagnosis, and treatment, including molecular targeted therapy. The journal publishes clinical and translational research in the field of liver cancer in both humans and experimental models. It publishes original and review articles and has an Impact Factor of 13.8. The journal is indexed and abstracted in various platforms including PubMed, PubMed Central, Web of Science, Science Citation Index, Science Citation Index Expanded, Google Scholar, DOAJ, Chemical Abstracts Service, Scopus, Embase, Pathway Studio, and WorldCat.
期刊最新文献
Nivolumab plus Ipilimumab: A Novel First-Line Combination Immunotherapy for Unresectable Hepatocellular Carcinoma. Erratum. Oncological Resectability Criteria for Hepatocellular Carcinoma in the Era of Novel Systemic Therapies: The Japan Liver Cancer Association and Japanese Society of Hepato-Biliary-Pancreatic Surgery Expert Consensus Statement 2023. A Phase 3 Study of Pembrolizumab Versus Placebo for Previously Treated Patients From Asia With Hepatocellular Carcinoma: Health-Related Quality of Life Analysis From KEYNOTE-394 MASLD and MetALD increase the risk of developing hepatocellular carcinoma and incident or decompensated cirrhosis: a Korean nationwide study
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1